14 Sep 2006 - AvTech Laboratories, a division of Eurofins Scientific, and Chimera Biotec GmbH have signed a cooperation agreement that combines Chimera's ultra-high sensitive immunoassay technology, Imperacer, with AvTech's expertise in state-of-the-art analytical services. Under the agreement, AvTech will serve as the primary provider of Imperacer in the United States.
Additionally, the partnership allows AvTech to provide clients worldwide with access to an analytical contract research organization (CRO) for routine analysis of clinical and non-clinical samples under good laboratory/ manufacturing practice conditions.
 |
www.bionity.com/news/e/57892 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/57892 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |